Publication: Flecainide With Ranolazine Combination Inhibits Nav 1.5 Activity of Triple-Negative Breast Cancer Cells (MDA-MB-231)
Loading...
Date
Authors
Advisor
item.page.editor
Editor
Department
Journal Title
Journal ISSN
Volume Title
Publisher
DOI
Type
Abstract
Description
Journal or Series
ISSN
2211-5463
ISBN
Rights
info:eu-repo/semantics/closedAccess
Keywords
Citation
Mammadova, G., Demirel, M., & Altun, S. (2025, July). Flecainide with ranolazine combination inhibits Nav 1.5 activity of triple-negative breast cancer cells (MDA-MB-231). In FEBS OPEN BIO (Vol. 15, pp. 303-303). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY.
Endorsement
Review
Supplemented By
Referenced By
27
Görüntülenme
0
İndirme
Google Scholar
Scholar'da Ara ↗ Bu yayında DOI yok — Altmetric/Dimensions/PlumX/BIP! rozetleri DOI gerektirir.